Is the peritoneal dialysis biocompatibility hypothesis dead?
- 1 August 2018
- journal article
- editorial
- Published by Elsevier in Kidney International
- Vol. 94 (2) , 246-248
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Neutral pH and low–glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysisKidney International, 2018
- Significant Decreasing Incidence of Encapsulating Peritoneal Sclerosis in the Dutch Population of Peritoneal Dialysis PatientsPeritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 2017
- Effect of Neutral-pH, Low–Glucose Degradation Product Peritoneal Dialysis Solutions on Residual Renal Function, Urine Volume, and UltrafiltrationClinical Journal of the American Society of Nephrology, 2015
- Extracellular volume expansion, measured by multifrequency bioimpedance, does not help preserve residual renal function in peritoneal dialysis patientsKidney International, 2014
- The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patientsKidney International, 2013
- Longitudinal membrane function in functionally anuric patients treated with APD: Data from EAPOS on the effects of glucose and icodextrin prescriptionKidney International, 2005
- Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat modelKidney International, 2005
- Morphologic Changes in the Peritoneal Membrane of Patients with Renal DiseaseJournal of the American Society of Nephrology, 2002